Real-life effect of elexacaftor/tezacaftor/ivacaftor therapy on microbiological findings in patients with Cystic fibrosis

被引：0
|
作者：
Lucca, Francesca [1 ]
Cucchetto, Giulia [1 ]
Paiola, Giulia [1 ]
Volpiilaria, Sonia [1 ]
Meneghelli, Illaria [1 ]
Pintani, Emily [1 ]
Cipolli, Marco [1 ]
机构：
[1] Cyst Fibrosis Ctr, Verona, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA3775
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
    Anderson, Ashlee
    McCoy, Lindsey
    Pettit, Rebecca S.
    Wright, Brittany A.
    Lubsch, Lisa
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 4053 - 4054
  • [42] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON CHRONIC SINONASAL SYMPTOMS IN ADULTS WITH CYSTIC FIBROSIS
    DiMango, E.
    Overdevest, J.
    Keating, C.
    Francis, Fracasso S.
    Dansky, D.
    Gudis, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S213 - S213
  • [43] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [44] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL OUTCOMES IN PEDIATRIC AND ADULT CYSTIC FIBROSIS PATIENTS
    Teibel, H.
    Burrus, T.
    Loy, S.
    Taylor, A.
    Sorgen, P.
    Pettit, R. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S248 - S249
  • [45] Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis
    Pioch, Charlotte O.
    Ziegahn, Niklas
    Allomba, Christine
    Busack, Leonie M.
    Schnorr, Alexandra N.
    Tosolini, Apolline
    Fuhlrott, Bent R.
    Zagkla, Styliani
    Othmer, Till
    Syunyaeva, Zulfiya
    Graeber, Simon Y.
    Yoosefi, Mehrak
    Thee, Stephanie
    Steinke, Eva
    Roehmel, Jobst
    Mall, Marcus A.
    Stahl, Mirjam
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 863 - 869
  • [46] Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
    O'Shea, Kate M.
    O'Carroll, Orla M.
    Carroll, Catherine
    Grogan, Brenda
    Connolly, Anna
    O'Shaughnessy, Lynda
    Nicholson, Trevor T.
    Gallagher, Charles G.
    McKone, Edward F.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [47] Effect of elexacaftor-tezacaftor- ivacaftor modulator on lung structure in cystic fibrosis
    Fainardi, V.
    Skenderaj, K.
    Ciuni, A.
    Esposito, S.
    Sverzellati, N.
    Pisi, G.
    PULMONOLOGY, 2023, 29 (05): : 441 - 443
  • [48] Triple Therapy for Cystic Fibrosis (Elexacaftor, Tezacaftor, and Ivacaftor): Desensitization After Skin Rash
    Santos, Ana Isabel
    Pacheco, Joana
    Cemlyn-Jones, Jessica
    Gamboa, Fernanda
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [49] Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis
    Dacco, Valeria
    Alicandro, Gianfranco
    Trespidi, Laura
    Gramegna, Andrea
    Blasi, Francesco Arturo
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2023, 308 (05) : 1657 - 1659
  • [50] Cardiopulmonary exercise test (CPET) in people with Cystic Fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
    Retucci, Mariangela
    Gramegna, Andrea
    Colombo, Crizia
    Gambazza, Simone
    Mariani, Alessandra
    Tammaro, Serena
    Vicenzi, Marco
    Russo, Maria
    Tomarelli, Irene
    Dacco, Valeria
    Blasi, Francesco
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345